Olema Pharmaceuticals, Inc. (OLMA) DCF Valuation

Olema Pharmaceuticals, Inc. (OLMA) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Olema Pharmaceuticals, Inc. (OLMA) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Discover the true potential of Olema Pharmaceuticals, Inc. (OLMA) with our advanced DCF Calculator! Adjust key assumptions, explore various scenarios, and evaluate how changes affect Olema Pharmaceuticals, Inc. (OLMA) valuation – all within a single Excel template.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -4.3 -21.5 -69.4 -103.1 -104.6 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .0 .0 1.7 1.7 .4 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -4.3 -21.5 -71.1 -104.8 -105.0 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash .1 338.5 287.3 204.4 261.8 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .3 .7
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 -.4 -.3 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .9 .7 .0 .4 2.7 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 -.1 -1.6 -.4 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -4.3 -22.2 -70.9 -102.6 -105.0 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -3.4 -22.4 -71.1 -101.3 -102.9 -2.0 .0 .0 .0 .0
WACC, % 13.97 13.97 13.97 13.97 13.97 13.97 13.97 13.97 13.97 13.97
PV UFCF
SUM PV UFCF -1.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -2
Net Debt -66
Equity Value 64
Diluted Shares Outstanding, MM 45
Equity Value Per Share 1.42

What You Will Get

  • Pre-Filled Financial Model: Olema Pharmaceuticals’ actual data allows for accurate DCF valuation.
  • Full Forecast Control: Modify revenue growth, profit margins, WACC, and other essential drivers.
  • Instant Calculations: Real-time updates ensure you see results as you implement changes.
  • Investor-Ready Template: A polished Excel file crafted for high-quality valuation.
  • Customizable and Reusable: Designed for adaptability, facilitating repeated use for in-depth forecasts.

Key Features

  • Comprehensive DCF Model: Features detailed unlevered and levered DCF valuation models tailored for Olema Pharmaceuticals, Inc. (OLMA).
  • WACC Analysis Tool: Pre-configured Weighted Average Cost of Capital sheet with adjustable parameters.
  • Customizable Forecast Inputs: Adjust growth projections, capital investments, and discount rates as needed.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to Olema Pharmaceuticals, Inc. (OLMA).
  • Interactive Dashboard and Graphs: Visual representations that highlight essential valuation metrics for straightforward analysis.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered Olema Pharmaceuticals data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for Olema Pharmaceuticals' intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator?

  • User-Friendly Interface: Perfect for both novice and seasoned users.
  • Customizable Inputs: Adjust parameters to suit your financial analysis needs.
  • Real-Time Feedback: Observe immediate updates to Olema Pharmaceuticals’ valuation as you change inputs.
  • Pre-Loaded Data: Comes with Olema Pharmaceuticals’ actual financial information for swift evaluations.
  • Valued by Experts: Utilized by investors and analysts for insightful decision-making.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling Olema Pharmaceuticals stock (OLMA).
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models for Olema Pharmaceuticals (OLMA).
  • Consultants: Deliver professional valuation insights on Olema Pharmaceuticals (OLMA) to clients quickly and accurately.
  • Business Owners: Understand how biotech companies like Olema Pharmaceuticals (OLMA) are valued to guide your own strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios related to Olema Pharmaceuticals (OLMA).

What the Template Contains

  • Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Olema Pharmaceuticals, Inc. (OLMA).
  • Real-World Data: Olema’s historical and projected financials preloaded for thorough analysis.
  • Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into performance.
  • Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
  • Dashboard with Visual Outputs: Charts and tables designed for clear, actionable insights.

Es wurden keine passenden Produkte gefunden.